All Stories

  1. Re: Manuscript titled, “Liver transplantation for sickle cell disease: a systematic review”

    Article • HPB, February 2021, Elsevier

    Juliet Emamaullee

  2. Meta‐analysis and meta‐regression of outcomes for adult living donor liver transplantation versus deceased donor liver transplantation

    Article • American Journal of Transplantation, January 2021, Wiley

    Juliet Emamaullee

  3. Association of Sex and Race/Ethnicity With National Institutes of Health Funding of Surgeon-Scientists

    Article • JAMA Surgery, December 2020, American Medical Association (AMA)

    Juliet Emamaullee

  4. Rapid Adaptation of a Surgical Research Unit to Conduct Clinical Trials During the COVID-19 Pandemic

    Article • Journal of Surgical Research, December 2020, Elsevier

    Juliet Emamaullee

  5. Living donor financial assistance programs in liver transplantation: The global perspective

    Article • Clinical Transplantation, September 2020, Wiley

    Juliet Emamaullee

  6. Health‐related quality of life after anonymous nondirected living liver donation: A multicenter collaboration

    Article • American Journal of Transplantation, September 2020, Wiley

    Juliet Emamaullee

  7. Long-Term Financial, Psychosocial, and Overall Health-Related Quality of Life After Living Liver Donation

    Article • Journal of Surgical Research, September 2020, Elsevier

    Juliet Emamaullee

  8. LIVING DONOR INCENTIVIZATION AND REIMBURSEMENT IN LIVER TRANSPLANTATION: THE GLOBAL PERSPECTIVE

    Article • Transplantation, September 2020, Wolters Kluwer Health

    Juliet Emamaullee

  9. Research priorities in Fontan-associated liver disease

    Article • Current Opinion in Organ Transplantation, August 2020, Wolters Kluwer Health

    Juliet Emamaullee

  10. A Healthy Liver After SVR: Food for Thought

    Article • Digestive Diseases and Sciences, August 2020, Springer Science + Business Media

    Juliet Emamaullee

  11. Global experience and perspective on anonymous nondirected live donation in living donor liver transplantation

    Article • Clinical Transplantation, March 2020, Wiley

    Juliet Emamaullee

  12. Immunologic benefit of maternal donors in pediatric living donor liver transplantation

    Article • Pediatric Transplantation, August 2019, Wiley

    Juliet Emamaullee

  13. Chronically Retained Central Venous Catheter in Deceased Donor Liver Allograft

    Article • Case Reports in Transplantation, April 2019, Hindawi Publishing Corporation

    Juliet Emamaullee

  14. Case report of hemorrhagic shock from spontaneous gallbladder rupture in a patient with advanced liver disease awaiting liver transplant

    Article • HPB, March 2019, Elsevier

    Juliet Emamaullee

  15. HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation

    Article • Canadian Journal of Gastroenterology and Hepatology, January 2019, Hindawi Publishing Corporation

    Juliet Emamaullee

  16. Islet Cell Transplantation

    Article • January 2019, Elsevier

    Juliet Emamaullee

  17. Case series and systematic review of acquired diaphragmatic hernia after liver transplantation

    Article • Pediatric Transplantation, October 2018, Wiley

    Juliet Emamaullee

  18. Hepatic Epithelioid Hemangioendothelioma Presenting as an Enlarging Vascular Lesion within the Spleen

    Article • Case Reports in Transplantation, January 2018, Hindawi Publishing Corporation

    Juliet Emamaullee

  19. Caspase Inhibitor IDN6556 Facilitates Marginal Mass Islet Engraftment in a Porcine Islet Autotransplant Model

    Article • Transplantation, July 2012, Wolters Kluwer Health

    Juliet Emamaullee

  20. AEB071 (sotrastaurin) does not exhibit toxic effects on human islets in vitro nor after transplantation into immunodeficient mice

    Article • Islets, November 2011, Taylor & Francis

    Juliet Emamaullee

  21. The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice

    Article • Surgery, July 2011, Elsevier

    Juliet Emamaullee

  22. Clinical Islet Transplantation

    Article • January 2011, Elsevier

    Juliet Emamaullee

  23. Hepatobiliary and Pancreatic: Multinodular fatty liver associated with porphyria cutanea tarda

    Article • Journal of Gastroenterology and Hepatology, December 2010, Wiley

    Juliet Emamaullee

  24. Caspase Inhibitor Therapy Synergizes With Costimulation Blockade to Promote Indefinite Islet Allograft Survival

    Article • Diabetes, March 2010, American Diabetes Association

    Juliet Emamaullee

  25. Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture

    Article • Transplant International, March 2010, Wiley

    Juliet Emamaullee

  26. Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management

    Article • Liver Transplantation, February 2010, Wiley

    Juliet Emamaullee

  27. Histologic Graft Assessment After Clinical Islet Transplantation

    Article • Transplantation, December 2009, Wolters Kluwer Health

    Juliet Emamaullee

  28. Costimulatory blockade with belatacept in clinical and experimental transplantation – a review

    Article • Expert Opinion on Biological Therapy, May 2009, Informa Healthcare

    Juliet Emamaullee

  29. Porcine Marginal Mass Islet Autografts Resist Metabolic Failure Over Time and Are Enhanced by Early Treatment with Liraglutide

    Article • Endocrinology, May 2009, Endocrine Society

    Juliet Emamaullee

  30. Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice

    Article • Diabetes, March 2009, American Diabetes Association

    Juliet Emamaullee

  31. Protein Kinase C Inhibitor, AEB-071, Acts Complementarily With Cyclosporine to Prevent Islet Rejection in Rats

    Article • Transplantation, January 2009, Wolters Kluwer Health

    Juliet Emamaullee

  32. AEB-071 has minimal impact on onset of autoimmune diabetes in NOD mice

    Article • Autoimmunity, January 2009, Taylor & Francis

    Juliet Emamaullee

  33. Optimal implantation site for pancreatic islet transplantation

    Article • British Journal of Surgery, December 2008, Oxford University Press (OUP)

    Juliet Emamaullee

  34. The Role of Macrophage Migration Inhibitory Factor in Mouse Islet Transplantation

    Article • Transplantation, November 2008, Wolters Kluwer Health

    Juliet Emamaullee

  35. Liraglutide, a Long-Acting Human Glucagon-Like Peptide 1 Analog, Improves Glucose Homeostasis in Marginal Mass Islet Transplantation in Mice

    Article • Endocrinology, September 2008, Endocrine Society

    Juliet Emamaullee

  36. Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation

    Article • Transplant International, August 2008, Wiley

    Juliet Emamaullee

  37. INHIBITION OF TH17 CELLS REGULATES AUTOIMMUNE DIABETES.

    Article • Transplantation, July 2008, Wolters Kluwer Health

    Juliet Emamaullee

  38. The role of macrophage migration inhibitory factor on glucose metabolism and diabetes

    Article • Diabetologia, July 2008, Springer Science + Business Media

    Juliet Emamaullee

  39. Islet-Cell Transplant

    Article • March 2008, Taylor & Francis

    Juliet Emamaullee

  40. The Caspase Selective Inhibitor EP1013 Augments Human Islet Graft Function and Longevity in Marginal Mass Islet Transplantation in Mice

    Article • Diabetes, March 2008, American Diabetes Association

    Juliet Emamaullee

  41. Belatacept and Basiliximab Diminish Human Antiporcine Xenoreactivity and Synergize to Inhibit Alloimmunity

    Article • Transplantation, January 2008, Wolters Kluwer Health

    Juliet Emamaullee

  42. Islet Cell Transplantation

    Article • January 2008, Elsevier

    Juliet Emamaullee

  43. F.93. Caspase Inhibitor Therapy Promotes Tolerance Induction in Islet Transplantation

    Article • Clinical Immunology, January 2008, Elsevier

    Juliet Emamaullee

  44. Human Islet Function Is Not Impaired by the Sphingosine-1-Phosphate Receptor Modulator FTY720

    Article • American Journal of Transplantation, August 2007, Wiley

    Juliet Emamaullee

  45. Caspase Inhibitor Therapy Enhances Marginal Mass Islet Graft Survival and Preserves Long-Term Function in Islet Transplantation

    Article • Diabetes, February 2007, American Diabetes Association

    Juliet Emamaullee

  46. Factors Influencing the Loss of β-Cell Mass in Islet Transplantation

    Article • Cell Transplantation, January 2007, SAGE Publications

    Juliet Emamaullee

  47. Neonatal Porcine Islets Exhibit Natural Resistance to Hypoxia-Induced Apoptosis

    Article • Transplantation, October 2006, Wolters Kluwer Health

    Juliet Emamaullee

  48. Interventional Strategies to Prevent  -Cell Apoptosis in Islet Transplantation

    Article • Diabetes, June 2006, American Diabetes Association

    Juliet Emamaullee

  49. XIAP Overexpression in Human Islets Prevents Early Posttransplant Apoptosis and Reduces the Islet Mass Needed to Treat Diabetes

    Article • Diabetes, August 2005, American Diabetes Association

    Juliet Emamaullee

  50. XIAP Overexpression in Islet beta-Cells Enhances Engraftment and Minimizes Hypoxia-Reperfusion Injury

    Article • American Journal of Transplantation, June 2005, Wiley

    Juliet Emamaullee

  51. The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin

    Article • JBIC Journal of Biological Inorganic Chemistry, April 2001, Springer Science + Business Media

    Juliet Emamaullee